41.25
-0.09 (-0.22%)
| Previous Close | 41.34 |
| Volume | 201,866 |
| Price / Earnings (Forward) | 21.19 |
| Price / Sales | 2.01 |
| Price / Book | 2.11 |
| 52 Weeks Range | |
| TTM Dividend Yield | 2.32% |
| Profit Margin | 6.05% |
| Operating Margin (TTM) | 12.49% |
| Diluted EPS (TTM) | 1.25 |
| Quarterly Revenue Growth (YOY) | 29.90% |
| Quarterly Earnings Growth (YOY) | 183.50% |
| Total Debt/Equity (MRQ) | 42.94% |
| Current Ratio (MRQ) | 2.31 |
| Operating Cash Flow (TTM) | 271.20 M |
| Levered Free Cash Flow (TTM) | 176.09 M |
| Return on Assets (TTM) | 5.28% |
| Return on Equity (TTM) | 6.48% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (AU) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Bullish | Mixed | |
| Stock | ANSELL FPO [ANN] | - | - |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -4.0 |
| Technical Moving Averages | 1.5 |
| Technical Oscillators | 4.0 |
| Average | 1.31 |
|
Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 55% of revenue and operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents, and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly. Largest sales regions are North America and Europe, Middle East, and Africa. Asia-Pacific and Latin America, combined, are about one-fourth of sales. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Mid Value |
| % Held by Insiders | 1.32% |
| % Held by Institutions | 59.48% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |